References
- Ridker P, Cushman M, Stampfer M, Tracy R, Hennekens C. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973–9.
- Ridker P, Rifai N, Clearfield M, Downs J, Weis S, Miles J. Measurement of C-reactive protein for the targeting of statin therapy in the primary preven-tion of acute coronary events. N Engl J Med 2001; 344: 1959–65.
- Ridker P, Cushman M, Spampfer M, Tracy R, Hennekens C. Plasma concentration C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97: 425–8.
- Ridker P, Hennekens C, Buring J, Rifai N. C-reactive protein and other markers of inflamma-tion in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836–43.
- Koenic W, Sund M, Frohlich M, Fischer HhyphenG, Löwel H, Doring A, Hutchinson W, Pepys M. C-reactiveprotein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 1999; 99: 237–42.
- Ledue T, Rifai N. Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assess-ment. Clin Chem 2003; 49: 1258–71.
- Pearson T, Mensah G, Alexander R, Anderson J, Cannon III R, Cricqui M, Fadl Y, Fortman S, Hong Y, Myers G, Rifai N, Smith S, Taubert K, Tracy R, Vinicor F. AHA/CDC Scientific State-ment. Markers of inflammation and cardiovascu-lar disease. Application to clinical and public health practice. A statement for healthcare profes-sionals from the centers for disease control and prevention and the American Association. Circu-lation 2003; 107: 499–511.
- Hedberg P, Puukka M. Highly sensitive determi-nation of C-reactive protein on the Innotrac Aiol immunoanalyzer. Clin Chem Lab Med 2003; 41 Suppl. W-126: S426.
- Roberts W, Sedrick R, Moulton L, Spencer A, Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implica-tions for clinical and epidemiological applications. Clin Chem 2000; 46: 461–8.
- Roberts W, Moulton L, Law T, Farrow G, Cooper-Anderson M, Savory J, Rifai N. Evalua-tion of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001; 47: 418–25.